We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+6.58%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
AUM
$201M
AUM Growth
+$42.4M
Cap. Flow
+$33M
Cap. Flow %
16.42%
Top 10 Hldgs %
75.74%
Holding
348
New
9
Increased
90
Reduced
25
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 11.87%
2 Consumer Discretionary 4.23%
3 Healthcare 3.62%
4 Financials 3.4%
5 Industrials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSN icon
326
Tyson Foods
TSN
$20.6B
$1K ﹤0.01%
21
VTRS icon
327
Viatris
VTRS
$19B
$1K ﹤0.01%
46
WRAP icon
328
Wrap Technologies
WRAP
$109M
$1K ﹤0.01%
399
NVTA
329
DELISTED
Invitae Corporation
NVTA
$1K ﹤0.01%
645
DCP
330
DELISTED
DCP Midstream, LP
DCP
$1K ﹤0.01%
25
BND icon
331
Vanguard Total Bond Market
BND
$157B
$0 ﹤0.01%
1
BNDX icon
332
Vanguard Total International Bond ETF
BNDX
$82.1B
$0 ﹤0.01%
1
BYND icon
333
Beyond Meat
BYND
$272M
$0 ﹤0.01%
1
CENN icon
334
Cenntro
CENN
$8.41M
0
CHWY icon
335
Chewy
CHWY
$9.59B
$0 ﹤0.01%
1
CIVI
336
DELISTED
Civitas Resources
CIVI
$0 ﹤0.01%
6
IWF icon
337
iShares Russell 1000 Growth ETF
IWF
$127B
-124,352
Closed -$6.49M
ONON icon
338
On Holding
ONON
$12.4B
$0 ﹤0.01%
28
OXY.WS icon
339
Occidental Petroleum Corp Warrants
OXY.WS
$32.2B
$0 ﹤0.01%
6
FIRY
340
Firy Inc
FIRY
$156M
$0 ﹤0.01%
23
SNAP icon
341
Snap
SNAP
$8.83B
$0 ﹤0.01%
50
VVOS icon
342
Vivos Therapeutics
VVOS
$4.47M
$0 ﹤0.01%
48
VXUS icon
343
Vanguard Total International Stock ETF
VXUS
$158B
$0 ﹤0.01%
2
ENFY
344
DELISTED
Enlightify Inc
ENFY
$0 ﹤0.01%
121
TSP
345
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$0 ﹤0.01%
181
CLVS
346
DELISTED
Clovis Oncology, Inc.
CLVS
$0 ﹤0.01%
140
TWTR
347
DELISTED
Twitter, Inc.
TWTR
-42
Closed -$2K
NLSN
348
DELISTED
Nielsen Holdings plc
NLSN
-230
Closed -$6K

Similar funds

Kozak & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Kozak & Associates held 348 positions worth $201M, up 27% from $159M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Kozak & Associates deployed $33M of net new capital in Q4 2022, opening 9 new positions and adding to 90 existing holdings. Its largest new stake was iShares US Tech Independence Focused ETF: 536,056 shares worth $21.9M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $245K trimmed.

  • Kozak & Associates's largest Q4 2022 buy was iShares US Tech Independence Focused ETF: 536,056 shares worth $21.9M.
  • Kozak & Associates added most to State Street Health Care Select Sector SPDR ETF in Q4 2022, an estimated $1.04M increase.
  • Kozak & Associates's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $245K.
  • Kozak & Associates fully exited iShares Russell 1000 Growth ETF in Q4 2022, selling an estimated $6.49M.
  • Kozak & Associates's ten largest holdings make up 76% of its $201M portfolio in Q4 2022.
  • Kozak & Associates opened 9 new positions and closed 3 in Q4 2022.
  • Kozak & Associates's portfolio value rose 27% quarter-over-quarter to $201M.

Based on Kozak & Associates's 13F filing for Q4 2022, filed 3 Jan 2023.